CVS Health stock trades at EUR 78.89 with volume 67.0 percent below average

Published on 10/08/2026 at 19:08 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

CVS Health stock costs EUR 78.89 on October 8, 2026 after EUR 78.59, plus 0.38 percent. Results are due November 4, 2026.

Key points in brief

CVS Health stock was EUR 78.89 at Lang & Schwarz on October 8, 2026, up 0.38 percent from EUR 78.59.
Trading volume was 2,635,932 shares, 67.0 percent below the average of 7,968,243 shares.
The NYSE quote was USD 88.44 at 1:07 p.m. ET, with a market capitalization of USD 112.8 billion.
CVS Health is scheduled to report third-quarter 2026 results on November 4, 2026.

Isometrische 3D-Illustration der Gesundheitsversorgungskette von Produktion über Apotheke bis Patient — CVS Health Corp. isometrisches 3D-Diagramm der Wertschöpfungskette von Pharma bis Patient, ISIN US1266501006, Illustration mit AI erstellt.

CVS Health stock was EUR 78.89 at Lang & Schwarz on October 8, 2026 at 7:03 p.m. CEST, up 0.38 percent versus the prior close of EUR 78.59. Trading volume reached 2,635,932 shares, 67.0 percent below the average of 7,968,243 shares, making participation the clearest near-term market signal.

Volume stays below average

The volume comparison puts the session in perspective: the stock moved only 0.38 percent while turnover reached 33.1 percent of its average level. The lower activity gives the price move less statistical weight than a session with volume near the 7,968,243-share average.

At 1:07 p.m. ET on October 8, 2026, the NYSE quote stood at USD 88.44. That quote is separate from the euro price at Lang & Schwarz and was intraday rather than an officially labeled closing price.

Valuation and yearly range

CVS Health had a market capitalization of USD 112.8 billion on October 8, 2026, with a trailing price-to-earnings ratio of 23.4 and a dividend yield of 3.0 percent. Its USD 69.51 to USD 110.68 52-week range places the NYSE quote 20.1 percent below the yearly high.

MarketBeat reported on October 6, 2026 that 22 of 23 analysts rated CVS Health a Buy and that the average target was USD 107.24. The target stood 21.2 percent above the USD 88.44 NYSE quote on October 8, 2026.

Comparison with peers

CVS Health Corp.: plus 0.38 percent, P/E 23.4, market capitalization USD 112.8 billion
UnitedHealth Group (NYSE, USD): minus 0.80 percent, P/E 24.0, market capitalization USD 338.7 billion
Humana (NYSE, USD): minus 3.38 percent, P/E 36.2, market capitalization USD 46.0 billion

Next report date

CVS Health had set November 4, 2026 for its third-quarter 2026 results, according to Simply Wall St. The scheduled date gives the market a defined calendar point after the October 8 trading session.